Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 353 entries
Sorted by: Best Match Show Resources per page
Administration of Medroxprogesterone Acetate after Endomyometrial Resection.

The Journal of the American Association of Gynecologic Laparoscopists

Maia H, Marques D, Calmon LC, Coutinho E.
PMID: 9074171
J Am Assoc Gynecol Laparosc. 1996 Aug;3(4):S27-8. doi: 10.1016/s1074-3804(96)80227-1.

Seventy women (age 32-47 yrs) with a history of menorrhagia were evaluated by transvaginal sonography, hysteroscopy, and endometrial biopsy. Hysteroscopy revealed a normal uterine cavity in 60 patients, endometrial polyps in 4, and submucous myomas in 6. Endometrial biopsy...

Cite
Maia H, Marques D, Calmon LC, et al. Administration of Medroxprogesterone Acetate after Endomyometrial Resection. J Am Assoc Gynecol Laparosc. 1996;3(4):S27-8doi: 10.1016/s1074-3804(96)80227-1.
Maia, H., Marques, D., Calmon, L. C., & Coutinho, E. (1996). Administration of Medroxprogesterone Acetate after Endomyometrial Resection. The Journal of the American Association of Gynecologic Laparoscopists, 3(4), S27-8. https://doi.org/10.1016/s1074-3804(96)80227-1
Maia, et al. "Administration of Medroxprogesterone Acetate after Endomyometrial Resection." The Journal of the American Association of Gynecologic Laparoscopists vol. 3,4 (1996): S27-8. doi: https://doi.org/10.1016/s1074-3804(96)80227-1
Maia H, Marques D, Calmon LC, Coutinho E. Administration of Medroxprogesterone Acetate after Endomyometrial Resection. J Am Assoc Gynecol Laparosc. 1996 Aug;3(4):S27-8. doi: 10.1016/s1074-3804(96)80227-1. PMID: 9074171.
Copy Download .nbib Format: NLM
Prognostic importance of DNA-ploidy and S-phase fraction in endometrial cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Von Minckwitz G, Kühn W, Kaufmann M, Feichter GE, Heep J, Schmid H, Bastert G.
PMID: 11578414
Int J Gynecol Cancer. 1994 Jul;4(4):250-256. doi: 10.1046/j.1525-1438.1994.04040250.x.

On fresh frozen tumor tissue from 161 patients with endometrial cancer DNA-ploidy and S-phase fraction were measured in a prospective study to evaluate their prognostic and predictive value. All FIGO stage I or II patients had surgery and were...

Cite
Von Minckwitz G, Kühn W, Kaufmann M, et al. Prognostic importance of DNA-ploidy and S-phase fraction in endometrial cancer. Int J Gynecol Cancer. 1994;4(4):250-256doi: 10.1046/j.1525-1438.1994.04040250.x.
Von Minckwitz, G., Kühn, W., Kaufmann, M., Feichter, G. E., Heep, J., Schmid, H., & Bastert, G. (1994). Prognostic importance of DNA-ploidy and S-phase fraction in endometrial cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 4(4), 250-256. https://doi.org/10.1046/j.1525-1438.1994.04040250.x
Von Minckwitz, G., et al. "Prognostic importance of DNA-ploidy and S-phase fraction in endometrial cancer." International journal of gynecological cancer : official journal of the International Gynecological Cancer Society vol. 4,4 (1994): 250-256. doi: https://doi.org/10.1046/j.1525-1438.1994.04040250.x
Von Minckwitz G, Kühn W, Kaufmann M, Feichter GE, Heep J, Schmid H, Bastert G. Prognostic importance of DNA-ploidy and S-phase fraction in endometrial cancer. Int J Gynecol Cancer. 1994 Jul;4(4):250-256. doi: 10.1046/j.1525-1438.1994.04040250.x. PMID: 11578414.
Copy Download .nbib Format: NLM
Expression of estrogen receptors (alpha, beta) and insulin-like growth factor-I in breast tissue from surgically postmenopausal cynomolgus macaques after long-term treatment with HRT and tamoxifen.

Breast (Edinburgh, Scotland)

Isaksson E, Wang H, Sahlin L, von Schoultz B, Masironi B, von Schoultz E, Cline JM.
PMID: 14965685
Breast. 2002 Aug;11(4):295-300. doi: 10.1054/brst.2002.0422.

The novel estrogen receptor ERbeta could be a key factor for proliferation and breast cancer risk. In a primate model for long-term HRT, surgically postmenopausal cynomolgus macaques were treated for 35 months with conjugated equine estrogens (CEE), medroxyprogesterone acetate...

Cite
Isaksson E, Wang H, Sahlin L, et al. Expression of estrogen receptors (alpha, beta) and insulin-like growth factor-I in breast tissue from surgically postmenopausal cynomolgus macaques after long-term treatment with HRT and tamoxifen. Breast. 2002;11(4):295-300doi: 10.1054/brst.2002.0422.
Isaksson, E., Wang, H., Sahlin, L., von Schoultz, B., Masironi, B., von Schoultz, E., & Cline, J. M. (2002). Expression of estrogen receptors (alpha, beta) and insulin-like growth factor-I in breast tissue from surgically postmenopausal cynomolgus macaques after long-term treatment with HRT and tamoxifen. Breast (Edinburgh, Scotland), 11(4), 295-300. https://doi.org/10.1054/brst.2002.0422
Isaksson, E, et al. "Expression of estrogen receptors (alpha, beta) and insulin-like growth factor-I in breast tissue from surgically postmenopausal cynomolgus macaques after long-term treatment with HRT and tamoxifen." Breast (Edinburgh, Scotland) vol. 11,4 (2002): 295-300. doi: https://doi.org/10.1054/brst.2002.0422
Isaksson E, Wang H, Sahlin L, von Schoultz B, Masironi B, von Schoultz E, Cline JM. Expression of estrogen receptors (alpha, beta) and insulin-like growth factor-I in breast tissue from surgically postmenopausal cynomolgus macaques after long-term treatment with HRT and tamoxifen. Breast. 2002 Aug;11(4):295-300. doi: 10.1054/brst.2002.0422. PMID: 14965685.
Copy Download .nbib Format: NLM
Cervical dilation, conception rate, and concentrations of progesterone and estradiol-17B in postpartum ewes treated with porcine relaxin.

Theriogenology

Akinbami MA, Meredith S, Warren JE, Anthony RV, Day BN.
PMID: 16726893
Theriogenology. 1990 Nov;34(5):927-40. doi: 10.1016/0093-691x(90)90562-8.

Experiments were conducted to determine the effects of porcine relaxin (pRLX) on cervical dilation and conception rates in postpartum ewes. In Experiment 1, ewes received medroxyprogesterone acetate (MAP) sponge on day 16 (day 0 = lambing) and 750 IU...

Cite
Akinbami MA, Meredith S, Warren JE, et al. Cervical dilation, conception rate, and concentrations of progesterone and estradiol-17B in postpartum ewes treated with porcine relaxin. Theriogenology. 1990;34(5):927-40doi: 10.1016/0093-691x(90)90562-8.
Akinbami, M. A., Meredith, S., Warren, J. E., Anthony, R. V., & Day, B. N. (1990). Cervical dilation, conception rate, and concentrations of progesterone and estradiol-17B in postpartum ewes treated with porcine relaxin. Theriogenology, 34(5), 927-40. https://doi.org/10.1016/0093-691x(90)90562-8
Akinbami, M A, et al. "Cervical dilation, conception rate, and concentrations of progesterone and estradiol-17B in postpartum ewes treated with porcine relaxin." Theriogenology vol. 34,5 (1990): 927-40. doi: https://doi.org/10.1016/0093-691x(90)90562-8
Akinbami MA, Meredith S, Warren JE, Anthony RV, Day BN. Cervical dilation, conception rate, and concentrations of progesterone and estradiol-17B in postpartum ewes treated with porcine relaxin. Theriogenology. 1990 Nov;34(5):927-40. doi: 10.1016/0093-691x(90)90562-8. PMID: 16726893.
Copy Download .nbib Format: NLM
Comparison of two progestogens during out-of-season breeding in a commercial ewe flock.

Theriogenology

Tritschler JP, Duby RT, Parsons EM, Parsons MJ, Giordano DJ.
PMID: 16726962
Theriogenology. 1991 May;35(5):943-52. doi: 10.1016/0093-691x(91)90305-w.

A comparison was made of the relative effectiveness of subcutaneous ear implants containing 2 mg Norgestomet or vaginal pessaries containing 60 mg medroxyprogesterone acetate (MAP) to induce estrus and conception in dry anestrous ewes. Groups of ewes were treated...

Cite
Tritschler JP, Duby RT, Parsons EM, et al. Comparison of two progestogens during out-of-season breeding in a commercial ewe flock. Theriogenology. 1991;35(5):943-52doi: 10.1016/0093-691x(91)90305-w.
Tritschler, J. P., Duby, R. T., Parsons, E. M., Parsons, M. J., & Giordano, D. J. (1991). Comparison of two progestogens during out-of-season breeding in a commercial ewe flock. Theriogenology, 35(5), 943-52. https://doi.org/10.1016/0093-691x(91)90305-w
Tritschler, J P, et al. "Comparison of two progestogens during out-of-season breeding in a commercial ewe flock." Theriogenology vol. 35,5 (1991): 943-52. doi: https://doi.org/10.1016/0093-691x(91)90305-w
Tritschler JP, Duby RT, Parsons EM, Parsons MJ, Giordano DJ. Comparison of two progestogens during out-of-season breeding in a commercial ewe flock. Theriogenology. 1991 May;35(5):943-52. doi: 10.1016/0093-691x(91)90305-w. PMID: 16726962.
Copy Download .nbib Format: NLM
Serum progesterone determination as an aid for pregnancy diagnosis in goats bred out of season.

The Canadian veterinary journal = La revue veterinaire canadienne

Fleming SA, Van Camp SD, Chapin HM.
PMID: 17423508
Can Vet J. 1990 Feb;31(2):104-7.

Nubian does (n = 12) were bred by artificial insemination after induction of estrus with medroxyprogesterone acetate impregnated vaginal sponges and pregnant mare serum gonadotrophin injections during the anestrous season. Pregnancy status was predicted from serum samples collected 21...

Cite
Fleming SA, Van Camp SD, Chapin HM. Serum progesterone determination as an aid for pregnancy diagnosis in goats bred out of season. Can Vet J. 1990;31(2):104-7
Fleming, S. A., Van Camp, S. D., & Chapin, H. M. (1990). Serum progesterone determination as an aid for pregnancy diagnosis in goats bred out of season. The Canadian veterinary journal = La revue veterinaire canadienne, 31(2), 104-7.
Fleming, S A, et al. "Serum progesterone determination as an aid for pregnancy diagnosis in goats bred out of season." The Canadian veterinary journal = La revue veterinaire canadienne vol. 31,2 (1990): 104-7.
Fleming SA, Van Camp SD, Chapin HM. Serum progesterone determination as an aid for pregnancy diagnosis in goats bred out of season. Can Vet J. 1990 Feb;31(2):104-7. PMID: 17423508; PMCID: PMC1480631.
Copy Download .nbib Format: NLM
Comparative evaluation of raloxifene versus estrogen: Progestin on symptomatology, endometrium, and lipid profile in postmenopausal women.

Journal of mid-life health

Dogiparthi A, Aggarwal N, Suri V, Srinivasan R, Malhotra S.
PMID: 21799632
J Midlife Health. 2010 Jan;1(1):14-8. doi: 10.4103/0976-7800.66988.

The objective of the study was to evaluate the effects of raloxifene and estrogen progesterone (E + P) combination on symptoms, endometrium, and lipid profile in postmenopausal women. Ninety healthy postmenopausal women were enrolled and allocated to three groups...

Cite
Dogiparthi A, Aggarwal N, Suri V, et al. Comparative evaluation of raloxifene versus estrogen: Progestin on symptomatology, endometrium, and lipid profile in postmenopausal women. J Midlife Health. 2010;1(1):14-8doi: 10.4103/0976-7800.66988.
Dogiparthi, A., Aggarwal, N., Suri, V., Srinivasan, R., & Malhotra, S. (2010). Comparative evaluation of raloxifene versus estrogen: Progestin on symptomatology, endometrium, and lipid profile in postmenopausal women. Journal of mid-life health, 1(1), 14-8. https://doi.org/10.4103/0976-7800.66988
Dogiparthi, Anuradha, et al. "Comparative evaluation of raloxifene versus estrogen: Progestin on symptomatology, endometrium, and lipid profile in postmenopausal women." Journal of mid-life health vol. 1,1 (2010): 14-8. doi: https://doi.org/10.4103/0976-7800.66988
Dogiparthi A, Aggarwal N, Suri V, Srinivasan R, Malhotra S. Comparative evaluation of raloxifene versus estrogen: Progestin on symptomatology, endometrium, and lipid profile in postmenopausal women. J Midlife Health. 2010 Jan;1(1):14-8. doi: 10.4103/0976-7800.66988. PMID: 21799632; PMCID: PMC3139256.
Copy Download .nbib Format: NLM
Usefulness of 22-oxa-1,25-dihydroxyvitamin D-3 (OCT) as a single agent or combined therapy with aromatase inhibitor (CGS 16949A) on 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.

International journal of oncology

Andoh T, Iino Y.
PMID: 21541484
Int J Oncol. 1996 Jul;9(1):79-82. doi: 10.3892/ijo.9.1.79.

The antitumor effects of 22-oxa-1,25-dihydroxy-vitamin D-3 (OCT), a vitamin D-3 analogue, were evaluated on 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary tumors. The combined effects of OCT (0.3 mu g/kg) with tamoxifen (0.5 mg/kg) medroxyprogesterone acetate (MPA) 2.5 mg/kg), or a new...

Cite
Andoh T, Iino Y. Usefulness of 22-oxa-1,25-dihydroxyvitamin D-3 (OCT) as a single agent or combined therapy with aromatase inhibitor (CGS 16949A) on 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. Int J Oncol. 1996;9(1):79-82doi: 10.3892/ijo.9.1.79.
Andoh, T., & Iino, Y. (1996). Usefulness of 22-oxa-1,25-dihydroxyvitamin D-3 (OCT) as a single agent or combined therapy with aromatase inhibitor (CGS 16949A) on 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. International journal of oncology, 9(1), 79-82. https://doi.org/10.3892/ijo.9.1.79
Andoh, T, and Iino, Y. "Usefulness of 22-oxa-1,25-dihydroxyvitamin D-3 (OCT) as a single agent or combined therapy with aromatase inhibitor (CGS 16949A) on 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors." International journal of oncology vol. 9,1 (1996): 79-82. doi: https://doi.org/10.3892/ijo.9.1.79
Andoh T, Iino Y. Usefulness of 22-oxa-1,25-dihydroxyvitamin D-3 (OCT) as a single agent or combined therapy with aromatase inhibitor (CGS 16949A) on 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. Int J Oncol. 1996 Jul;9(1):79-82. doi: 10.3892/ijo.9.1.79. PMID: 21541484.
Copy Download .nbib Format: NLM
Mammographic density in postmenopausal women treated with tibolone, estriol or conventional hormone replacement therapy.

Clinical drug investigation

Valdivia I, Ortega D.
PMID: 23315352
Clin Drug Investig. 2000;20(2):101-7. doi: 10.2165/00044011-200020020-00005.

OBJECTIVE: To compare the effects of tibolone, estriol and conventional hormone replacement therapy (HRT) on mammographic parenchymal density in postmenopausal women.DESIGN AND SETTING: This was a non-randomised, prospective, longitudinal, comparative study conducted at two specialist outpatient clinics in Chile.PATIENTS...

Cite
Valdivia I, Ortega D. Mammographic density in postmenopausal women treated with tibolone, estriol or conventional hormone replacement therapy. Clin Drug Investig. 2000;20(2):101-7doi: 10.2165/00044011-200020020-00005.
Valdivia, I., & Ortega, D. (2000). Mammographic density in postmenopausal women treated with tibolone, estriol or conventional hormone replacement therapy. Clinical drug investigation, 20(2), 101-7. https://doi.org/10.2165/00044011-200020020-00005
Valdivia, I, and Ortega, D. "Mammographic density in postmenopausal women treated with tibolone, estriol or conventional hormone replacement therapy." Clinical drug investigation vol. 20,2 (2000): 101-7. doi: https://doi.org/10.2165/00044011-200020020-00005
Valdivia I, Ortega D. Mammographic density in postmenopausal women treated with tibolone, estriol or conventional hormone replacement therapy. Clin Drug Investig. 2000;20(2):101-7. doi: 10.2165/00044011-200020020-00005. PMID: 23315352.
Copy Download .nbib Format: NLM
Use of interferon and medroxyprogesterone acetate for the treatment of endometrial cancer.

Oncology reports

Angioli R, Sevin B, Untch M, Kochli O, Estape R, Averette H.
PMID: 21594371
Oncol Rep. 1996 Mar;3(2):351-4.

Endometrial cancer is a hormone sensitive tumor. Response rate to progestational therapy is related to steroid receptor expression of the tumor. Interferons have been shown to enhance hormonal receptors. In this study the effect of four different interferons and...

Cite
Angioli R, Sevin B, Untch M, et al. Use of interferon and medroxyprogesterone acetate for the treatment of endometrial cancer. Oncol Rep. 1996;3(2):351-4
Angioli, R., Sevin, B., Untch, M., Kochli, O., Estape, R., & Averette, H. (1996). Use of interferon and medroxyprogesterone acetate for the treatment of endometrial cancer. Oncology reports, 3(2), 351-4.
Angioli, R, et al. "Use of interferon and medroxyprogesterone acetate for the treatment of endometrial cancer." Oncology reports vol. 3,2 (1996): 351-4.
Angioli R, Sevin B, Untch M, Kochli O, Estape R, Averette H. Use of interferon and medroxyprogesterone acetate for the treatment of endometrial cancer. Oncol Rep. 1996 Mar;3(2):351-4. PMID: 21594371.
Copy Download .nbib Format: NLM
Transdermal progesterone: effects on menopausal symptoms and on thrombotic, anticoagulant, and inflammatory factors in postmenopausal women.

International journal of pharmaceutical compounding

Stephenson K, Neuenschwander PF, Kurdowska AK, Pinson B, Price C.
PMID: 23969765
Int J Pharm Compd. 2008 Jul-Aug;12(4):295-304.

Conventional hormone replacement therapy increases a woman's risk of thrombotic events as evidenced in large prospective clinical trials, including HERS I and the Women's Health Initiative. A possible mechanism for this is the unfavorable net effects of conjugated equine...

Cite
Stephenson K, Neuenschwander PF, Kurdowska AK, et al. Transdermal progesterone: effects on menopausal symptoms and on thrombotic, anticoagulant, and inflammatory factors in postmenopausal women. Int J Pharm Compd. 2008;12(4):295-304
Stephenson, K., Neuenschwander, P. F., Kurdowska, A. K., Pinson, B., & Price, C. (2008). Transdermal progesterone: effects on menopausal symptoms and on thrombotic, anticoagulant, and inflammatory factors in postmenopausal women. International journal of pharmaceutical compounding, 12(4), 295-304.
Stephenson, Kenna, et al. "Transdermal progesterone: effects on menopausal symptoms and on thrombotic, anticoagulant, and inflammatory factors in postmenopausal women." International journal of pharmaceutical compounding vol. 12,4 (2008): 295-304.
Stephenson K, Neuenschwander PF, Kurdowska AK, Pinson B, Price C. Transdermal progesterone: effects on menopausal symptoms and on thrombotic, anticoagulant, and inflammatory factors in postmenopausal women. Int J Pharm Compd. 2008 Jul-Aug;12(4):295-304. PMID: 23969765.
Copy Download .nbib Format: NLM
Comparison of piascledine (avocado and soybean oil) and hormone replacement therapy in menopausal-induced hot flashing.

Iranian journal of pharmaceutical research : IJPR

Panahi Y, Beiraghdar F, Kashani N, Baharie Javan N, Dadjo Y.
PMID: 24250433
Iran J Pharm Res. 2011;10(4):941-51.

Different symptoms in Climacteric period, includes hot flash. Hormone replacement therapy (HRT) is common therapy for relief of menopausal symptoms but has possible contraindications and side effects. Recently Piascledine (combination of Avocado oil with Soybean oil) showed effects in...

Cite
Panahi Y, Beiraghdar F, Kashani N, et al. Comparison of piascledine (avocado and soybean oil) and hormone replacement therapy in menopausal-induced hot flashing. Iran J Pharm Res. 2011;10(4):941-51
Panahi, Y., Beiraghdar, F., Kashani, N., Baharie Javan, N., & Dadjo, Y. (2011). Comparison of piascledine (avocado and soybean oil) and hormone replacement therapy in menopausal-induced hot flashing. Iranian journal of pharmaceutical research : IJPR, 10(4), 941-51.
Panahi, Yunes, et al. "Comparison of piascledine (avocado and soybean oil) and hormone replacement therapy in menopausal-induced hot flashing." Iranian journal of pharmaceutical research : IJPR vol. 10,4 (2011): 941-51.
Panahi Y, Beiraghdar F, Kashani N, Baharie Javan N, Dadjo Y. Comparison of piascledine (avocado and soybean oil) and hormone replacement therapy in menopausal-induced hot flashing. Iran J Pharm Res. 2011;10(4):941-51. PMID: 24250433; PMCID: PMC3813060.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 353 entries